Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @AACR
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AACR
-
African Americans experience a higher incidence of multiple myeloma but are often poorly represented in clinical trials. Join us and
@FDAOncology on Feb. 13 in Washington, DC as we discuss how to address this cancer care disparity.#MyelomaDiversity http://bit.ly/39f3JSs pic.twitter.com/mRgKJnvCGj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
African Americans experience a higher incidence of multiple myeloma but are often poorly represented in clinical trials. Join us and
@FDAOncology on Feb. 13 in Washington, DC as we discuss how to address this cancer care disparity.#MyelomaDiversity http://bit.ly/2ugTH4u pic.twitter.com/EyvUlpO6nt
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AACR proslijedio/la je Tweet
Public workshop: Feb 13 join us in person or online for
#FDAOncology -@AACR Workshop to Examine Under-representation of African Americans in Multiple Myeloma Clinical Trials -#MyelomaDiversity https://www.aacr.org/AdvocacyPolicy/GovernmentAffairs/Pages/multiple-myeloma-clinical-trials.aspx …pic.twitter.com/Td6v7UJ8hM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AACR Chief Policy Officer Jon Retzlaff discusses the tradition of partnership between
@FDAOncology and the AACR with@drjennifergao at today’s#OCEProject2025 meeting.pic.twitter.com/pS9wPKatRV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AACR proslijedio/la je Tweet
A message shared by everyone at
#FDAOncology! Read more about@realrickpazdur's thoughts on envisioning cancer drug development: https://www.fda.gov/about-fda/oncology-center-excellence/oce-annual-report …https://twitter.com/aesfCEO/status/1225089857762025472 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Zena Werb,
@UCSFCancer is just one of the AACR's many members who are using their research efforts to help defeat cancer.#WorldCancerDay
pic.twitter.com/KINI4a6h2pHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AACR proslijedio/la je Tweet
AACR Fellow Bruce W. Stillman, is one of many researchers advancing cancer science.
#WorldCancerDay
pic.twitter.com/68M8v2abcCHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RT
@AACR_CEO: On#WorldCancerDay
, the @AACR is pleased to join the@uicc and other supporting organizations in raising awareness about cancer and working to reduce its global impact.http://bit.ly/2GU4ynxHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In the past three years, the number of cancer survivors living in the United States increased by 1.4 million, reaching more than 16.9 million on January 1, 2019.
#WorldCancerDay
pic.twitter.com/gGFS5PZIHm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
African Americans experience a higher incidence of multiple myeloma but are often poorly represented in clinical trials. Join us and
@FDAOncology on Feb. 13 in Washington, DC as we discuss how to address this cancer care disparity.#MyelomaDiversity http://bit.ly/2GVMklG pic.twitter.com/Yl7nLxSUq0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AACR Past President Michael Caligiuri is just one of our members working towards advancing cancer research.
#WorldCancerDay
pic.twitter.com/no36QyX97WHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today is
#WorldCancerDay
. The AACR is the authoritative source of information about advances in the causes, diagnosis, treatment and prevention of cancer.http://bit.ly/2UnPXsp pic.twitter.com/ZEmdanvZWTHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
On the blog:
@US_FDA-AACR Workshop to Address Multiple Myeloma Clinical Trial Disparities.http://bit.ly/36ZVEQ9Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RT
@CEBP_AACR: V metric, a measure of mammographic texture, is positively associated with#BreastCancer risk. Oh et al find early-life BMI inversely associated with V suggesting lifelong impact of early adiposity#BreastTissue architecture.@ewarner_12 http://bit.ly/3b7a97V pic.twitter.com/xiVHfWv3CG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RT
@CR_AACR: Don't forget to vote for your favorite Cancer Research cover from 2019! http://bit.ly/2OEr3Bl pic.twitter.com/hTTjp4Ma0U
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AACR proslijedio/la je Tweet
African Americans experience a higher incidence of multiple myeloma but are often poorly represented in clinical trials. Feb 13 join us for a workshop on Under-representation of African Americans in Multiple Myeloma Clinical Trials -
#MyelomaDiversity https://www.aacr.org/AdvocacyPolicy/GovernmentAffairs/Pages/multiple-myeloma-clinical-trials.aspx …pic.twitter.com/fDca9OOgiK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We invite applications for funding from researchers at all career stages. Visit our website to learn more! http://bit.ly/2uYJzgz pic.twitter.com/VEtH5SLS0V
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tuesday is
#WorldCancerDay
. The AACR brings together the greatest minds in cancer research to advance a scientifically bold agenda against the collection of devastating diseases we call cancer. http://bit.ly/2ttetgM pic.twitter.com/2nfbUoiAl8Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AACR proslijedio/la je Tweet
Feb 13, join us for
#FDAOncology -@AACR Workshop to Examine Under-representation of African Americans in Multiple Myeloma Clinical Trials -#MyelomaDiversity https://www.aacr.org/AdvocacyPolicy/GovernmentAffairs/Pages/multiple-myeloma-clinical-trials.aspx …pic.twitter.com/ffn8qs89DG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RT
@MCT_AACR: Hingorani et al show that Auristatin#AntiHER2#Antibody conjugates injected and combined with focal ionizing radiation improved survival of mice with HER2-rich tumor#xenografts http://bit.ly/2GGczMy@UCSDMedSchool@UCSDHealthpic.twitter.com/pkfxZgkPiz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.